Screening of drugs with potential antifungal activity for repurposing in the treatment of cryptococcosis
Letters in Applied Microbiology · 2025
DOI: 10.1093/lambio/ovaf045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2025. Verfasst von Emanuel Almeida Moreira de Oliveira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Multicentric Program in Biochemistry and Molecular Biology, Universidade Federal de Juiz de Fora, 35032-620, Governador Valadares, Brazil. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Repositioning, Cryptococcus neoformans, Cryptococcosis. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Universidade Federal de Juiz de Fora.
Abstract (Originalsprache)
Current therapeutic alternatives for the treatment of cryptococcosis are scarce, highly toxic, expensive, and difficult to access. Therefore, the aim of this study was to evaluate the anticryptococcal potential of a collection of 27 drugs in vitro against several strains of Cryptococcus neoformans and Cryptococcus gattii. We investigated several parameters to evaluate the antifungal activity of the drugs: determination of minimum inhibitory concentration (MIC), combinatorial effects with fluconazole, kinetics of growth inhibition, post-antifungal effect (PAFE), and morphometric analyses at subinhibitory concentrations. Antiparasitics albendazole, fenbendazole, flubendazole, mebendazole, and antidepressants duloxetine and paroxetine showed antifungal activity with an MIC of 100 µmol l−1 or less for most strains tested. The results of the zero-interaction power model indicated additive effects for combination of fluconazole with drugs finasteride, hydroxyzine, and paroxetine. The combined treatments significantly improved the ability of fluconazole to kill C. neoformans ATCC H99. Same phenomenon occurred in the in vitro PAFE, as the combinations suppressed fungal growth more effectively than fluconazole alone. A significant reduction in capsule size was observed. Screening of the drug collection showed interesting results, with benzimidazoles antiparasitics and serotonin and norepinephrine reuptake inhibitors in foreground. Finasteride, hydroxyzine, and paroxetine significantly improved activity of fluconazole in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Multicentric Program in Biochemistry and Molecular Biology, Universidade Federal de Juiz de Fora, 35032-620, Governador Valadares, Brazil.
- Department of Pharmacy, Universidade Federal de Juiz de Fora, 35032-620, Governador Valadares, Brazil.
ORCID-Profile: Emanuel Almeida Moreira de Oliveira, Gabriella Freitas Ferreira, Karen Luise Lang
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Universidade Federal de Juiz de Fora
Zitieren
APA
de Oliveira, E. A. M., Ferreira, G. F., & Lang, K. L. (2025). Screening of drugs with potential antifungal activity for repurposing in the treatment of cryptococcosis. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovaf045
Vancouver
de Oliveira EAM, Ferreira GF, Lang KL. Screening of drugs with potential antifungal activity for repurposing in the treatment of cryptococcosis. Letters in Applied Microbiology. 2025. doi:10.1093/lambio/ovaf045
BibTeX
@article{deOliveira2025,
author = {de Oliveira, Emanuel Almeida Moreira and Ferreira, Gabriella Freitas and Lang, Karen Luise},
title = {Screening of drugs with potential antifungal activity for repurposing in the treatment of cryptococcosis},
journal = {Letters in Applied Microbiology},
year = {2025},
doi = {10.1093/lambio/ovaf045}
}
EUVIMED